Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q3 2023 · 10-Q
Revenue$2.59B$2.59B+3.8% vs Q3 2022 Net Income-$6.43M-$6.43MN/M vs Q3 2022 EPS Diluted-$0.08-$0.08N/M vs Q3 2022 Gross Profit$538,498,000+4.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$157,435,000+129.8% Free Cash Flowderived$109,707,000+410.7% Margins · derivedGross margin20.8%+0.2 pt vs Q3 2022
Operating margin0.9%−1.5 pt vs Q3 2022
Net margin-0.2%−0.7 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 3, 2023 · 34 d after period end